Treatment of Diastolic Dysfunction with Abnormal E' Values
For diastolic dysfunction with abnormal E' values, first-line treatments include beta-blockers to lower heart rate and increase diastolic filling time, followed by judicious use of diuretics and nitrates to reduce symptoms by lowering elevated filling pressures without significantly reducing cardiac output. 1
Pharmacological Management Algorithm
First-Line Therapies (Class I recommendations)
Beta-blockers
- Primary mechanism: Lower heart rate and increase diastolic filling period 1
- Allows more time for ventricular filling and improves diastolic function
- Start with low doses and titrate gradually to avoid hypotension
Diuretics
Nitrates
- Effective for symptom relief by reducing preload 1
- Particularly useful for patients with concurrent angina
Rate control medications (if atrial fibrillation present)
Second-Line Therapies (Class II recommendations)
Verapamil-type calcium channel blockers
ACE inhibitors
Treatment of Underlying Causes
Addressing causal or aggravating conditions is essential:
- Revascularization for coronary artery disease 1
- Control of systemic hypertension 1
- Management of tachyarrhythmias - prevention and restoration of sinus rhythm when possible 1
- Treatment of myocardial hypertrophy 2
Important Considerations and Pitfalls
- Avoid positive inotropic agents (Class III recommendation) in the absence of systolic dysfunction 1
- Avoid excessive diuresis which can lead to hypotension and decreased cardiac output 1
- Monitor for hypotension when initiating therapy, as patients with diastolic dysfunction rely on elevated filling pressures to maintain adequate cardiac output 1
- Calcium channel blockers should be avoided unless there is coexistent angina or hypertension 1
- Treatment of asymptomatic ventricular arrhythmias is not recommended (Class III) 1
Special Populations
For elderly patients (who commonly have diastolic dysfunction):
- Consider comorbidities that may affect treatment choices
- Start with lower medication doses and titrate more gradually
- Monitor for drug interactions with other medications 1
The treatment of diastolic dysfunction remains challenging due to limited evidence from clinical trials, as patients with preserved left ventricular function have been excluded from most major heart failure studies 1, 2. Pure diastolic dysfunction is relatively rare, often occurring with some degree of systolic dysfunction, making standardized treatment algorithms difficult to establish 1.